ERYTECH’s IPO a remarkable success, raising €17.7 million Post author:admERY Post published:April 30, 2013 Post category:Newsroom ERYTECH today announced the success of its IPO in compartment C of the NYSE Euronext regulated market in Paris, raising more than the target amount of €15 million. You Might Also Like ERYTECH Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy May 14, 2018 ERYTECH Announces Launch of Investigator-Initiated Phase 2 Study of eryaspase (GRASPA®) for ALL April 4, 2017 ERYTECH PHARMA : ANNUAL GENERAL MEETING OF JUNE 24, 2016 June 3, 2016
ERYTECH Strengthens Executive Team with the Appointment of Alex Dusek as VP of Commercial Strategy May 14, 2018
ERYTECH Announces Launch of Investigator-Initiated Phase 2 Study of eryaspase (GRASPA®) for ALL April 4, 2017